Related references
Note: Only part of the references are listed.Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Phase II/III randomized trial of TCH346 in patients with ALS
R. Miller et al.
NEUROLOGY (2007)
Statins in heart failure. Beyond the lipid lowering effect
Dimitris Tousoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Genetic risk factors associated with lipid-lowering drug-induced myopathies
Georgirene D. Vladutiu et al.
MUSCLE & NERVE (2006)
Statin-induced rhabdomyolysis
Donald H. Schreiber et al.
JOURNAL OF EMERGENCY MEDICINE (2006)
Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)
M. Muddasir Qureshi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Toward immunomodulatory and anti-inflammatory properties of statins
C Arnaud et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones
J Bösel et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters
Jean-Claude Desport et al.
NEURODEGENERATIVE DISEASES (2005)
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:: benefit of a high-energy diet in a transgenic mouse
L Dupuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Amyotrophic lateral sclerosis:: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum
SD Süssmuth et al.
NEUROSCIENCE LETTERS (2003)
Statin-associated myopathy
PD Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Creatine kinase activity in amyotrophic lateral sclerosis patients
J Ilzecka et al.
NEUROLOGICAL SCIENCES (2003)
Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis
LS Krivickas et al.
MUSCLE & NERVE (2002)
Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis
RG Cutler et al.
ANNALS OF NEUROLOGY (2002)
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?
D Gaist et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
